Sergi Verdes
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting Amyotrophic Lateral Sclerosis with Gene Therapy: From Silencing Genes to Enhancing Neuroprotection.
Journal: Human gene therapy
Published: September 04, 2025
Long-term effects of s-KL treatment in wild-type mice: Enhancing longevity, physical well-being, and neurological resilience.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 06, 2025
An in vitro and in vivo efficacy evaluation of gene therapy candidate SBT101 in mouse models of adrenomyeloneuropathy and in NHPs.
Journal: Molecular therapy. Methods & clinical development
Published: April 30, 2024
Long-term effects of s-KL treatment in wild-type mice: Enhancing longevity, physical well-being, and neurological resilience.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 21, 2024
Differential toxicity profile of secreted and processed α-Klotho expression over mineral metabolism and bone microstructure.
Journal: Scientific reports
Published: October 19, 2022
Proteomic quantitative study of dorsal root ganglia and sciatic nerve in type 2 diabetic mice.
Journal: Molecular metabolism
Published: July 08, 2021
Gene Therapy Overexpressing Neuregulin 1 Type I in Combination With Neuregulin 1 Type III Promotes Functional Improvement in the SOD1G93A ALS Mice.
Journal: Frontiers in neurology
Published: April 10, 2021
Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: February 05, 2021
Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: January 23, 2020
Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1G93A ALS mice.
Journal: Neurobiology of disease
Published: October 30, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026